Skip to main content
HCPCS J2430 · Level II · Part B drug

J2430: pamidronate disodium, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2430

Billing unit
30 MG
Pamidronate disodium /30 mg
ASP payment limit
$11.306
October 2026; -6.0% vs July 2026
Practitioner MUE
3
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
1
4 states

TL;DR

HCPCS J2430 is the Level II code for Injection, pamidronate disodium, per 30 mg, billed per 30 MG. The Medicare Part B ASP payment limit for October 2026 is $11.306 per billing unit, down 6.0% from July 2026. The practitioner MUE allows up to 3 units per date of service (MAI 3), so a full 3-unit day is $33.92 at the current limit. Under OPPS it carries status indicator N. J2430 is billed in units of 30 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 5 NDCs to it, sold as Pamidronate Disodium by Pfizer Inc, Mylan Institutional LLC. 1 Medicare coverage article lists the code across 4 states, including A56907.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2430 at $11.306 per 30 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $12.025 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2430
QuarterPayment limitPerCoinsurance
October 2026$11.30630 MG20%
July 2026$12.02530 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 5 NDCs from 2 labelers to J2430. Report the NDC in the claim's drug segment and bill the number of J2430 units that equals the quantity administered divided by 30 MG; the last column gives units per full package.

NDCs that crosswalk to J2430
NDCDrug nameLabelerPackage sizeBilling units / package
61703-0324-18Pamidronate DisodiumPfizer Inc10 × 11
61703-0325-18Pamidronate DisodiumPfizer Inc10 × 12
61703-0326-18Pamidronate DisodiumPfizer Inc10 × 13
67457-0430-10Pamidronate DisodiumMylan Institutional LLC10 × 11
67457-0446-10Pamidronate DisodiumMylan Institutional LLC1 × 13

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2430. For practitioners the limit is 3 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2430 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services33 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital33 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J2430 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2430 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2430 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2430 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J2430 in their HCPCS tables, covering 4 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J2430
ArticleTitleContractor(s)StatesRelated LCD
A56907Billing and Coding: Bisphosphonate Drug TherapyWisconsin Physicians Service Insurance CorporationIA KS MO NEL34648, L39721

Diagnoses Medicare contractors cover for J2430

One billing and coding article attaches a covered diagnosis list to J2430: 155 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J2430
ICD-10-CMDescription (FY2027)Articles covering
C50.011Malignant neoplasm of nipple and areola, right female breast1 of 1
C50.012Malignant neoplasm of nipple and areola, left female breast1 of 1
C50.021Malignant neoplasm of nipple and areola, right male breast1 of 1
C50.022Malignant neoplasm of nipple and areola, left male breast1 of 1
C50.111Malignant neoplasm of central portion of right female breast1 of 1
C50.112Malignant neoplasm of central portion of left female breast1 of 1
C50.121Malignant neoplasm of central portion of right male breast1 of 1
C50.122Malignant neoplasm of central portion of left male breast1 of 1
C50.211Malignant neoplasm of upper-inner quadrant of right female breast1 of 1
C50.212Malignant neoplasm of upper-inner quadrant of left female breast1 of 1
C50.221Malignant neoplasm of upper-inner quadrant of right male breast1 of 1
C50.222Malignant neoplasm of upper-inner quadrant of left male breast1 of 1
C50.311Malignant neoplasm of lower-inner quadrant of right female breast1 of 1
C50.312Malignant neoplasm of lower-inner quadrant of left female breast1 of 1
C50.321Malignant neoplasm of lower-inner quadrant of right male breast1 of 1
140 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J2430 are counted here: a group whose instructions name J2430, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J2430, by article
ArticleContractorGroups that applyCovered codes for J2430Full list
A56907Wisconsin Physicians Service Insurance Corporationgroup 2 applies to J2430155On LCD L34648

Local coverage policies that list J2430

1 active Local Coverage Determination lists J2430 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2430 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2430 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2430 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2430

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2430

What does HCPCS code J2430 describe?

J2430 is defined by CMS as "Injection, pamidronate disodium, per 30 mg". Each billing unit represents 30 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2430 a CPT code?

No. J2430 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as pamidronate disodium; CPT codes are five-character codes maintained by the AMA. On a Part B claim J2430 reports the drug itself in 30 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2430 in October 2026?

The ASP-based payment limit is $11.306 per 30 MG, with 20% beneficiary coinsurance. The July 2026 limit was $12.025. Commercial payers use their own fee schedules.

How many units of J2430 can be billed per day?

The practitioner Medically Unlikely Edit is 3 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J2430?

The October 2026 ASP crosswalk lists 5 NDCs from 2 labelers: Pamidronate Disodium (Pfizer Inc); Pamidronate Disodium (Mylan Institutional LLC). For example NDC 61703-0324-18 (package size 10) equals 1 billing unit of J2430.

Does J2430 have NCCI bundling edits?

No active practitioner PTP pairs list J2430 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J2430?

1 current Billing and Coding Article in the Medicare Coverage Database lists J2430, covering 4 states: A56907 (Billing and Coding: Bisphosphonate Drug Therapy).

What diagnosis codes support J2430?

One Medicare billing and coding article lists 155 covered ICD-10-CM codes for J2430, for example C50.011 (Malignant neoplasm of nipple and areola, right female breast); C50.012 (Malignant neoplasm of nipple and areola, left female breast); C50.021 (Malignant neoplasm of nipple and areola, right male breast); C50.022 (Malignant neoplasm of nipple and areola, left male breast); C50.111 (Malignant neoplasm of central portion of right female breast). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.